Uygulaması Korkunç Sonuçları Olan İlaçlar
Özet
Hastalıklar karşısında çarelerini bulmak için öteden beri birçok yol ve yöntem geliştirilmeye çalışıldı. Bunlar bazen cerrahi bir müdahale bazen de ile ilaçlar yolu ile oldu. Sistemik olarak ilaç uygulama yöntemleri çoğu zaman popüler olsa da her şey istenildiği gibi yolunda gitmeyebiliyor. Klinik yararları düşünülerek geliştirilen ilaçlar beklenenin aksine kullanımları sonrası erken veya geç dönemde olumsuz durumlar ortaya çıkarabiliyor. Bu kapsamda öncesinde yeterince klinik araştırma yapılmayan, güvenlik ve kalite standardı dışında geliştirilen ajanlar toplumsal sorunlara neden oldu. Bunlar arasında eliksir sülfanilamid ve talidomid faciaları geniş kitlelerde derin yaralar açan unutulmayacak sonuçlar doğurmuştur.
Many ways and methods had long been tried to developed heal for diseases. These sometimes had through surgical intervention and sometimes through drug medications. Although systemic drug administration methods are often popular, not everything may go as planned. Drugs developed with clinical benefits in mind, contrary to expectations, may cause negative effects in the early or late periods after their use. In this context, agents without sufficient clinical research and developed outside of safety and quality standards caused social problems. Among these, the elixir sulfanilamide and thalidomide disasters caused unforgettable results that reason deep wounds in large masses.
Referanslar
Alan Wayne Jones. Early drug discovery and the rise of pharmaceutical chemistry. Drug Test Anal. 2011;3(6):337-44.
R J Miller, P B Tran. More mysteries of opium reveal'd: 300 years of opiates. Trends Pharmacol Sci. 2000;21(8):299-304.
Jung-Hung Chen, I-Hsin Lin, Thomas Y Hsueh, Jeffrey W Dalley, Tung-Hu Tsai. Pharmacokinetics and transplacental transfer of codeine and codeine metabolites from Papaver somniferum L. J Ethnopharmacol. 2022;298:115623.
Tıp, TDV İslâm Ansiklopedisi, 2012;(41), 95-101 İstanbul.
Risâle-i Mu’âlece’ye Göre On Altıncı Yüzyıl Osmanlı Tıbbında Bitkisel Tedavi Şekilleri ve Terminoloji Yıl 2022, Cilt 23, Sayı 2, 261 - 290, 01.07.2022
Global Use of Medicines 2023 – Outlook through 2027 from the IQVIA Institute for Human Data Science. January 2023.
Jiangshan Wang, Rob van der Heijden, Shannon Spruit, Thomas Hankermeier, Kelvin Chan, Jan van der Greef, Guowang Xu, Mei Wang. Quality and safety of Chinese herbal medicines guided by a systems biology perspective. J Ethnopharmacol. 2009;29;126(1):31-41.
Chin YW, Balunas MJ, Chai HB, Kinghorn AD. Drug discovery from natural sources. The AAPS journal. 2006;8:E239-53.
James H Kim, Anthony R Scialli. Thalidomide: the tragedy of birth defects and the effective treatment of disease. Toxicol Sci. 2011;122(1):1-6.
Juan R Coca, Raquel Coca-Asensio, Gema Esteban Bueno. Socio-historical analysis of the social importance of pharmacovigilance. Front Sociol. 2022;7:974090.
Carol Ballentine. Sulfanilamide Disaster. FDA Consumer magazine. June 1981 Issue. U.S. Food and Drug Administration. www.fda.gov
Cooper Dale E. Adequate controls for new drugs: good manufacturing practice and the 1938 Federal Food, Drug and Cosmetic Act. Pharm. Hist. 2002;44, 12–23.
Martínez-Frías, ML. Talidomida: 50 años después. Med. Clín.2012;139,25–32.
Buharalıoğlu C K, Buharalıoğlu G Y. Effects of thalidomide disaster on the development of pharmacovigilance activities. Mersin Univ Saglık Bilim Derg 2019;12(1).
Kim JH, Scialli AR. Thalidomide: the tragedy of birth defects and the effective treatment of disease. Toxicol Sci. 2011 Jul;122(1):1-6.
Paine M F. Therapeutic disasters that hastened safety testing of new drugs. Clin Pharmacol Ther. 2017;101(4):430-434.
Vargesson N. Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res C Embryo Today. 2015;105(2):140-56.
Vargesson N. Thalidomide-induced limb defects: resolving a 50-year-old puzzle. BioEssays 2009;31:1327–1336
James E Ridings. The thalidomide disaster, lessons from the past. Methods Mol Biol. 2013;947:575-86.
Donald D. Davis, Steven M. Kane. Phocomelia In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2022;2022 Jun 21.
Bruno Almeida Costa, Tarek H Mouhieddine, Joshua Richter. What's Old is New: The Past, Present and Future Role of Thalidomide in the Modern-Day Management of Multiple Myeloma. Target Oncol. 2022;17(4):383-405.
Richard M Fleming, Larry B Boyd. The longitudinal effects of fenfluramine-phentermine use. Angiology. 2007;58(3):353-9.
Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaffet HV. Valvular heart disease associated with fenfluramine–phentermine. N Engl J Med. 1997;337(9):581–588.
Teramae CY, Connolly HM, Grogan M, Jr Miller FA. Diet drug-related cardiac valve disease: the Mayo Clinic echocardiographic laboratory experience. Mayo Clin Proc. 2000;75(5):456–461.
Abenhaim L, Moride Y, Brenot F, et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med. 1996;335(9):609–616.
Mohadese K, Haleh T, Mehrzad M, Masoud M. Consequences of Opioid Abuse and their Treatments in Persian Medicine: A Review Study. Addict Health. 2020;12(1):46-57.
United Nations General Assembly. Transforming our World: The 2030 Agenda for Sustainable Development. New York, NY: United Nations Population Fund; 2015.
Khademi H, Kamangar F, Brennan P, Malekzadeh R. Opioid Therapy and its side effects: A Review. Arch Iran Med. 2016; 19: 870-876
UN. The International Narcotics Control Board (INCB). Single Convention on Narcotic Drugs, 1961.
Nalini Vadiv, Leandro Lumermann, Richard Zhu, Gopal Kodumudi, Amir O Elhassan, Alan David Kaye. Pain Control in the Presence of Drug Addiction. Curr Pain Headache Rep. 2016;20(5):35.
Xeno Rasmusson. History and Policy of Clinical Cannabis versus Medical Marijuana: U.S. History and Policy. Journal of Social Science for Policy Implications. 2014; 2(1): 15-30.
Fraguas-Sánchez A.I, Torres-Suárez A.I. Medical Use of Cannabinoids. Drugs. 2018;78:1665–1703.
Haney M., Hart C.L., Vosburg S.K., Nasser J., Bennett A., Zubaran C., Foltin R.W. Marijuana Withdrawal in Humans: Effects of Oral THC or Divalproex. Neuropsychopharmacology. 2003;29:158–170.
Carley DW, Prasad B, Reid KJ, Malkani R, Attarian H, Abbott SM, Vern B, Xie H, Yuan C, Zee PC. Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial: Effects of Dronabinol in Obstructive Sleep Apnea. Sleep. 2018;01;41(1)
Petrilli K, Ofori S, Hines L, Taylor G, Adams S, Freeman T. Association of cannabis potency with mental ill health and addiction: a systematic review. Lancet Psychiatry. 2022; 9:736–50.
A Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 11th Edition. Hardman JG, Limbird LE, Gilman AG, editors. New York: McGraw-Hill, 2011. p.93-198.
Al B, The Source-Synthesis- History and Use of Atropine. JAEM 2014;13:2-3.
Geiger and Hesse. Darstellung des Atropins (Preparation of atropine). Annalen der Pharmacie 1833;5:43-81
Michael Manogue, David S Hirsh, Michael Lloyd. Cardiac electrophysiology of patients with spinal cord injury. Heart Rhythm. 2017;14(6):920-927.
Oliver Freudenreich. Drug-induced sialorrhea. Drugs Today (Barc). 2005;41(6):411-8.
Robert J Evans. Intravesical therapy for overactive bladder. Curr Urol Rep. 2005;6(6):429-33.
Karsten Fatur, Samo Kreft. Common anticholinergic solanaceaous plants of temperate Europe - A review of intoxications from the literature (1966-2018). Toxicon. 2020;15;177:52-88.
John M. Gowdy. Stramonium intoxication. J. Am. Med. Assoc., 1972; 221(6) :585
Svend Norn, Henrik Permin, Edith Kruse, Poul R Kruse. Mercury a major agent in the history of medicine and alchemy. Dan Medicinhist Arbog. 2008;36:21-40.
Eknoyan, G. A history of edema and its management. Kidney International Supplement . 1997; 59, 118-126.
Wile D. Diuretics: a review. Ann Clin Biochem. 2012;49(5):419-31.
Houston, M.C. Role of Mercury Toxicity in Hypertension, Cardiovascular Disease, and Stroke. J. Clin. Hyperten. 2011;13, 621–627.
Fillion, M. Mergler, D. Sousa Passos, C.J. Larribe, F. Lemire, M. Guimarães, J.R.D. A preliminary study of mercury exposure and blood pressure in the Brazilian Amazon. Environ. Health 2006;5: 29.
Giuseppe Genchi, Maria Stefania Sinicropi, Alessia Carocci, Graziantonio Lauria, Alessia Catalano. Mercury Exposure and Heart Diseases. Int J Environ Res Public Health 2017; 12;14(1):74.
Seungho Lee, Jin Hee Kim, Hyo-Bang Moon, Jeongim Park, Guyuyeon Choi, Sungkyoon Kim. Effects of mercury exposure on fetal body burden and its association with infant growth. Environ Res. 2023;15;217:114780.
Derek Ho, Eve J Lowenstein. Fowler's Solution and the Evolution of the Use of Arsenic in Modern Medicine. Skinmed. 2016;14(4):287-289.
Yong-Ming Li. Three Waves of Arsenic Therapy for Leukemia and Related Innovations. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2017;37(4):401-405.
Soile Tapio, Bernd Grosche. Arsenic in the aetiology of cancer. Mutat Res. 2006;612(3):215-246.
Mazumdar M, Valeri L, Rodrigues EG, Ibne Hasan MO, Hamid R, Paul L, bSelhub J, Silva F, Mostofa MG, Quamruzzaman Q, Rahman M, Christiani DC. Polymorphisms in maternal folate pathway genes interact with arsenic in drinking water to influence risk of myelomeningocele. Birth Defects. Res A Clin Mol Teratol. 2015;103:754-62
Ocak B. Frenginin tedavisinde salvarsan ile Neosalvarsan’ın keşfi ve bazı osmanlı hekimlerinin bu İlaçlar hakkındaki değerlendirmeleri. Journal of History School (JOHS). 2019; XL:296-311.
Sreepadmanabh M, Amit Kumar Sahu, Ajit Chande. COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development. J Biosci. 2020;45(1):148.
